Skip to main content

Fast Facts

North Carolina is a leading state in the life sciences, with 600-plus company locations statewide. That number includes:

  • More than 130 contract research and testing companies -- the world's greatest concentration;
  • More than 80 agricultural biotechnology companies in North Carolina;
  • More than 20 publicly traded companies with a market capitalization exceeding $30 billion;
  • More than 90 companies based on North Carolina university technologies;
  • More than 60,000 employees working directly in NC's life science companies;
  • 30.9 percent growth from 2000 to 2012, the fastest of the top 10 biotech states;
  • Estimated $5.4 billion payroll;
  • Average salary of $81,786 (2012);
  • $1.8 billion in state and local taxes;
  • More than 180 bioscience patents granted each year to companies and universities.

Major Companies Include:

  • Almac Group
  • Aurobindo Pharma
  • BASF
  • Baxter Healthcare
  • Bayer
  • Biogen
  • FUJIFILM Diosynth Biotechnologies
  • GlaxoSmithKline
  • Grifols
  • LabCorp
  • Mayne Pharma
  • Merck
  • Novo Nordisk
  • Patheon
  • Pfizer
  • PPD
  • Seqirus
  • Stallergenes Greer
  • Syngenta
  • Quintiles

Annual Impact of Biotechnology on North Carolina Agriculture:

  • Food and fiber production boosted by 86.6 million pounds in 2006
  • Pesticide use reduced by 3.5 million pounds in 2006

Biotechnology Products Discovered, Developed or Manufactured in North Carolina:

  • Drugs for a wide range of diseases including multiple sclerosis, diabetes, cancer, HIV/AIDS, psoriasis, Alzheimer's Disease;
  • Industrial enzymes for detergents, baking, agriculture and fuels;
  • Pest-resistant and herbicide-tolerant crops;
  • Poultry vaccines and feed supplements; and
  • Vaccines.

Verified July 2014